Kurage

What Kurage does

Kurage SAS is a French privately-held medtech company incorporated in Villeurbanne (Lyon), developing the NeuroSkin® Class IIa medical device, a wearable garment that integrates Functional Electrical Stimulation (FES, tSCS, NMES, TENS) with AI-driven continuous motion analysis to assist gait and movement rehabilitation. Embedded motion and pressure sensors capture gait data, while the company's proprietary algorithm — derived from over a decade of R&D and 40+ years of academic FES research at the University of Belgrade — adaptively stimulates up to 12 muscle groups bilaterally. The device is supported by a connected web and mobile application for personalized settings, progress visualization, and clinician remote supervision. The company operates the MotiMove stimulator (the hardware core, FDA-cleared as a wearable gait analysis component) and integrates with Gait Lab systems.

Kurage generates revenue through a combination of hardware sales or rentals of the NeuroSkin device, structured 12-week NeuroSkin Therapy programs (blending on-site sessions at Kurage centers and partner clinics with at-home supervised sessions), and clinical/professional packages sold to physiotherapy practices and rehabilitation centers (sold as multi-year subscriptions). The go-to-market is hybrid: direct sales at owned centers in France (Lyon, Paris, Boulogne-Billancourt) and Canada (Montréal), supplemented by a channel of certified partner clinics across Canada (five sites in Québec and Ontario) and France (Lab Neuro Paris). Customers span two primary segments — patients with neurological movement disorders (post-stroke, multiple sclerosis, spinal cord injury, cerebral palsy, ADEM) and healthcare professionals (physiotherapists and rehabilitation physicians) — with referral pathways through clinicians and through patient-facing assessment days.

The company is co-founded and led by Rudi Gombauld (CEO), Amine Metani (PhD, CSO, biophysics), and Lana Popovic Maneski (PhD, CTO, biomedical engineer, member of Academy of Sciences). Scientific alliances include ENS/CNRS, the French Red Cross, APF France Handicap, University of Belgrade, and IRCCS Maugeri (Italy). Clinical evidence includes a 2025 multicenter feasibility study on 15 subacute post-stroke patients showing +47.7% improvement on the Timed Up and Go test and +39.5% on the 2-Minute Walk Test after 10 sessions. No funding rounds, revenue, or headcount figures beyond the 11–50 employee band are publicly disclosed.

Name

Kurage

Legal name

KURAGE SAS

Website

https://kurage.fr

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Kurage SAS is a French medtech company that develops NeuroSkin®, a Class IIa wearable medical device combining AI-driven motion analysis with multi-channel functional electrical stimulation to deliver gait and motor rehabilitation for patients with neurological disorders (post-stroke, MS, spinal cord injury) and the physiotherapists treating them in France and Canada.

Ownership category

akta.pro rank

Product category

Neurorehabilitation Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Other Measuring and Controlling Device Manufacturing (334519)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

akta.pro secondary industries

Healthcare & Assistive Robotics (HDAAAIAC), Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices) (CRACAQAK)

Keywords

• Functional electrical stimulation
• Wearable neurorehabilitation devices
• Gait rehabilitation technology
• Neurostimulation medical devices
• Motion analysis algorithms

Headquarters

HQ city

Lyon

HQ country

France

HQ region

Europe

Offices8 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. NeuroSkin Device Sales: Sale or rental of the NeuroSkin hardware device (Class IIa medical device) which is an intelligent garment with integrated sensors and stimulation capabilities. The device is used both in clinical settings and at home.
2. NeuroSkin Therapy Program: Structured 12-week rehabilitation program combining on-site sessions at Kurage centers or certified partner clinics, and at-home sessions with remote supervision. Includes personalized support from specialists and continuous protocol adaptation.
3. Clinical/Professional Use Equipment and Services: Equipment and training packages sold to healthcare professionals and rehabilitation centers. Kurage provides training, installation, and ongoing support for clinical implementation.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Kurage develops and sells NeuroSkin®, a Class IIa medical device that is a wearable intelligent garment combining Functional Electrical Stimulation (FES) with continuous AI-driven motion analysis algorithms. The device uses integrated motion and pressure sensors to analyze movement in real time and automatically activates muscles (across up to 12 muscle groups) at the right moment through gentle electrical impulses to facilitate natural movement in patients with neurological disorders. It is delivered through a structured 12-week therapy program at Kurage's own rehabilitation centers, certified partner clinics, and at home with remote supervision.

Product overview

Kurage offers a unified product ecosystem centered on NeuroSkin®, a Class IIa medical device wearable garment. The system combines multi-channel Functional Electrical Stimulation (FES) technology with continuous motion analysis algorithms. The core NeuroSkin® device works in conjunction with the MotiMove electrical stimulator (the hardware core) and a connected web/mobile application for control and monitoring. A 12-week NeuroSkin® Therapy program provides structured rehabilitation protocols, extending the clinical work into home use through remote supervision via connected tools.

Differentiator

Problem solved

Functional benefit

Brands

• NeuroSkin: AI-driven wearable functional electrical stimulation (FES) device in the form of an intelligent garment for neurorehabilitation, targeting people with neurological movement disorders (stroke, multiple sclerosis, spinal cord injury). Class IIa medical device.

Products and services

• NeuroSkin® Wearable FES Device Class IIa medical device wearable garment combining Functional Electrical Stimulation (FES) with continuous AI-driven motion analysis. Embedded motion and pressure sensors analyze movement in real time, automatically activating up to 12 muscle groups bilaterally (gluteus maximus, quadriceps, hamstrings, tibialis anterior, gastrocnemius, peroneals) via FES, tSCS, NMES, and TENS impulses up to 170 mA. Designed for clinical and at-home use by patients with neurological movement disorders (stroke, multiple sclerosis, spinal cord injury, cerebral palsy).
• NeuroSkin® Web and Mobile Application Connected digital ecosystem (web and mobile) that lets users personalize stimulation settings (frequency, duration, intensity), select exercise modes (sitting, standing, walking, stairs, cycling), and view real-time performance feedback. Patient data is shared with clinicians for therapy adaptation and supports remote supervision of at-home use.
• NeuroSkin® Therapy Program Structured 12-week rehabilitation program combining physical exercises and intelligent neurostimulation. Includes personalized support and supervision by Kurage specialists, with continuous adaptation of protocols based on patient progress. Combines on-site sessions at Kurage centers or certified partner clinics with at-home sessions and remote supervision. A pre-conditioning protocol of 12 sessions is offered when home use is not yet suitable.
• Clinical Equipment, Training and Support Package B2B offering for healthcare professionals (physiotherapists, rehabilitation physicians) and rehabilitation centers that bundles the NeuroSkin device with installation, training, and ongoing support for clinical implementation. Includes ability to integrate patient session data with clinic systems and Gait Lab for detailed outcome reporting.

Quantifiable outcome

• Subacute post-stroke patients showed +47.7% improvement on Timed Up and Go (TUG) test and +39.5% on 2-Minute Walk Test (2MWT) after 10 sessions
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature6 records

Partnerships

Eleven partnerships are on record, tiered core and major.

• ENS / CNRScoreStrategic or Co-development PartnerScientific partnerships with leading French research institutions (École Normale Supérieure / Centre National de la Recherche Scientifique) for clinical research and technology development.
• APF France HandicapcoreStrategic or Co-development PartnerCo-development of solutions with APF France Handicap, a major French association representing people with disabilities. Patients are at the heart of Kurage's innovation process.
• French Red Cross (Croix-Rouge française)coreStrategic or Co-development PartnerCo-development partnership with the French Red Cross for neurorehabilitation solutions. Both organizations collaborate on making care more accessible.
• Universities and Research LaboratoriescoreStrategic or Co-development PartnerActive collaborations with universities and research laboratories in Europe and North America that test and validate NeuroSkin technologies, including University of Belgrade (40+ years of FES research).
• Medical and Research CenterscoreStrategic or Co-development PartnerPartnerships with medical and research centers across Europe and North America that conduct clinical validation studies, including IRCCS Maugeri Montescano in Italy.
• Montreal NeurotherapiemajorChannel Partner/ Reseller/ DistributorCertified NeuroSkin partner clinic in Montreal, Quebec (H3P 3P1). Phone: (514) 481-7867. Provides NeuroSkin therapy services to local patients.
• Terrebonne NeurothérapiemajorChannel Partner/ Reseller/ DistributorCertified NeuroSkin partner clinic in Terrebonne, Quebec (J6W 5S6). Provides localized NeuroSkin therapy services.
• Clinique SynapsemajorChannel Partner/ Reseller/ DistributorCertified NeuroSkin partner clinic in Quebec City (G2K 0N8). Phone: (418) 842-7888. Provides NeuroSkin therapy services.
• Toronto NeurochangersmajorChannel Partner/ Reseller/ DistributorCertified NeuroSkin partner clinic in Toronto, Ontario (M8V 3L1). Phone: (416) 679-9255. Website: neurochangers.ca.
• Toronto Propel PhysiotherapymajorChannel Partner/ Reseller/ DistributorCertified NeuroSkin partner clinic in Toronto, Ontario (M9C 4Z5). Phone: 866-210-6335. Website: propelphysiotherapy.com.
• Lab Neuro ParismajorChannel Partner/ Reseller/ DistributorPartner location in Paris (750013) offering NeuroSkin therapy services.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Hasomed: Hasomed (Germany) develops the RehaMove and SciMove functional electrical stimulators used in clinical research and rehabilitation for stroke and spinal cord injury. Comparable as a direct FES technology peer whose stimulators often pair with motion-triggered control algorithms, targeting the same research and clinical rehab customers.
• Restorative Therapies: Restorative Therapies makes the RT300 functional electrical stimulation cycling and stepping systems for spinal cord injury, MS, and stroke rehabilitation in clinics and at home. Comparable as a direct FES therapy peer targeting the same neurological indications and hybrid clinical-plus-home delivery model.
• Saebo: Saebo designs and sells upper- and lower-limb rehabilitation devices for stroke and neurological injury, including the SaeboStim FES microgarment. Comparable as a direct peer selling FES-based wearables to the same neurorehab patient and clinician segments as Kurage.
• Bioness: Bioness is a direct competitor in wearable functional electrical stimulation devices for foot drop and hand rehabilitation in stroke and other neurological conditions, offering the L300 Go and H200 wireless systems. Comparable because both sell clinic-and-home FES neurostimulation hardware to similar patient populations and prescribing clinicians.

Broad incumbents

• Ottobock: Ottobock is a global incumbent in prosthetics, orthotics, and neurostimulation, with the L300 Go and successor FES products serving stroke and MS patients. Comparable because Ottobock competes head-to-head with Kurage in clinical FES for gait rehabilitation, but as part of a much broader portfolio of mobility and rehab products.

Emerging players

• Tyromotion: Tyromotion (Austria) provides robotic and sensor-based rehabilitation devices for upper and lower limb therapy across neurological indications. Comparable as an emerging player selling advanced rehab technology to the same European clinic and medico-social customers Kurage serves.
• ReWalk Robotics: ReWalk Robotics produces wearable exoskeletons for spinal cord injury and stroke gait rehabilitation, with both clinical and personal-use systems. Comparable as an emerging player in advanced gait rehabilitation technology pursuing the same neurological patient population as Kurage, with a different modality (exoskeleton vs. FES).
• Bertec Corporation: Bertec builds instrumented treadmills, balance platforms, and gait analysis systems used in clinical rehabilitation and research, with strong overlap in spatiotemporal and baropodometric measurement. Comparable as an emerging peer in objective gait assessment that Kurage explicitly integrates with via Gait Lab.
• Ekso Bionics: Ekso Bionics develops wearable robotic exoskeletons (EksoNR) for stroke and spinal cord injury gait rehabilitation in clinical settings. Comparable as an adjacent technology peer competing for the same neurorehab budget and patient population, but with a clinic-bound robotic exoskeleton rather than a wearable FES garment.
• Myolyn: Myolyn develops functional electrical stimulation cycling systems (MyoCycle) for people with spinal cord injury, MS, and stroke in clinics and homes. Comparable as an emerging FES therapy peer targeting the same neurological indications and hybrid clinical-plus-home use case as Kurage's NeuroSkin Therapy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@kurage_tech
• Facebookfacebook.com/kuragetech
• LinkedInlinkedin.com/company/kurage
• Instagraminstagram.com/kurage_tech

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kurage